
National Association of Testing Authorities, Australia
Scope of Accreditation
Safe Work Laboratories Pty Ltd
Safework Health
Site
Safe Work Laboratories Pty Ltd – Brisbane
Safework Health
Accreditation No.
18874
Site No.
24739
Date of Accreditation
21 Oct 2019
Contact
Ms Natasha Laugier P: +61 (07) 35523001
Availability
Services available to external clients
Scope of Accreditation
Safe Work Laboratories Pty Ltd – Brisbane
ISO/IEC 17025 (2017)
Human Testing for Workplace and/or Community Screening
| Service | Product | Determinant | Technique | Procedure |
|---|---|---|---|---|
| Monitoring for residues, hydrocarbons and other contaminants of the environment (excluding pesticides) | Urine | Phenol | GC-MS | in-house method LAB - WI - 5631 - SWL - Phenol in Urine GCMS Method |
| Isocyanates; s-Phenyl mercapturic acid | Triple Quad LC-MS-MS | in-house method LAB - WI - 5657 - SWL - Isocyanate Exposure in Urine LCMS Method In-house method LABWI - 19626 – SWL - Benzene Exposure Analysis in Urine - LC/MS/MS Method |
ISO/IEC 17025 (2017)
Legal
| Service | Product | Determinant |
|---|---|---|
| Analysis for sports drugs and drug metabolites | Human urine | Salbutamol |
| Medico legal drug testing AS/NZS 4308:2008, section 5 Laboratory confirmatory procedures | Urine | Fentanyl; Norfentanyl; Noroxycodone; Oxycodone |
| Medico legal drug testing AS/NZS 4308:2023, Appendix A, Additional and optional testing | Urine | 1-(2-[4-Morpholinyl]ethyl)-1H-indol-3-yl-1-naphthalenylmethanone; 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 6-Acetylmorphine; Buprenorphine; Diazepam; Ecgonine methyl ester; Ephedrine; Fentanyl; Ketamine; N-Desmethyl cis tramadol; Norbuprenorphine; Norfentanyl; Norketamine; Noroxycodone; Oxycodone; Phentermine; Pseudoephedrine (PSE); Tramadol |
| Medico legal drug testing AS/NZS 4308:2023, Section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature |
| Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Oxidants; Specific gravity; Tetrahydrocannabinol (THC) metabolites; pH |
| Medico legal drug testing AS/NZS 4308:2023, Section 4 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2023, Section 5 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Tetrahydrocannabinol (THC) metabolites |
| Medico legal drug testing AS/NZS 4308:2023, Section 6 Laboratory confirmatory procedures | Urine | 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamine; Benzoylecgonine (ecgonine benzoate); Codeine; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nordiazepam; Oxazepam; Temazepam; α-Hydroxyalprazolam |
| Medico legal drug testing AS/NZS 4760, appendix B Additional testing | Oral fluid | Alprazolam; Benzodiazepines; Clonazepam; Diazepam; Ecgonine methyl ester; Fentanyl; Flunitrazepam; Ketamine; Nimetazepam; Nordiazepam; Oxazepam; Phentermine; Temazepam; Tramadol |
| Medico legal drug testing AS/NZS 4760, section 2 Collection, storage, handling and dispatch | Oral fluid | Handling and dispatch; Sample collection and storage |
| Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures | Oral fluid | 6-Acetylmorphine; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Clonazepam; Cocaine; Codeine; Diazepam; Ecgonine methyl ester; Flunitrazepam; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nitrazepam; Nordiazepam; Oxazepam; Oxycodone; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Quantitative analysis of non-animal/non-human samples for drugs and other substances | Filters; Swabs; Wipes | Amphetamines; Ephedrine; Methamphetamine; Pseudoephedrine (PSE) |
Client Sites
ISO/IEC 17025 (2017)
Legal
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Tetrahydrocannabinol (THC) metabolites; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
18874
Site No.
24739
Print date
20 Jan 2026
END OF SCOPE